MP Healthcare Venture Management logo

MP Healthcare Venture Management

North America, Massachusetts, United States, Boston

Description

MPH is the venture capital arm of Mitsubishi Tanabe Pharma Corp

Investor Profile

MP Healthcare Venture Management has made 42 investments, with 4 in the past 12 months and 10% as lead.

Stage Focus

  • Series B (26%)
  • Seed (24%)
  • Series A (21%)
  • Series C (14%)
  • Series Unknown (12%)
  • Series D (2%)

Country Focus

  • United States (50%)
  • United Kingdom (14%)
  • Switzerland (10%)
  • Belgium (7%)
  • Canada (5%)
  • Japan (5%)
  • Israel (2%)
  • Denmark (2%)
  • Germany (2%)
  • Italy (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Pharmaceutical
  • Medical
  • Biopharma
  • Life Science
  • Genetics
  • Precision Medicine
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does MP Healthcare Venture Management frequently co-invest with?

Amgen Ventures
North America, California, United States, San Francisco
Co-Investments: 5
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 6
Johnson & Johnson Development Corporation
North America, New Jersey, United States, New Brunswick
Co-Investments: 4
Atlas Venture
North America, Massachusetts, United States, Cambridge
Co-Investments: 6
Andera Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 4
SR One
North America, Massachusetts, United States, Cambridge
Co-Investments: 7
Dementia Discovery Fund
Europe, England, United Kingdom, London
Co-Investments: 6
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 5
Inkef
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 3
M Ventures
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 7

Which angels does MP Healthcare Venture Management often collaborate with?

Stephen Thompson
Oceania, Victoria, Australia, Melbourne
Shared Deals: 1
JM
North America, Massachusetts, United States, Cambridge
Shared Deals: 1

What are some of recent deals done by MP Healthcare Venture Management?

TRIMTECH Therapeutics

Cambridge, Massachusetts, United States

TRIMTECH Therapeutics treats inflammatory and persistent CNS conditions by focusing on the elimination of harmful proteins.

BiotechnologyMedicalTherapeutics
SeedMar 5, 2025
Amount Raised: $31,000,000
Libero Thera

Nihombashi-hamacho, Tokyo, Japan

Libero Thera provides drug discovery research and development services.

BiopharmaBiotechnologyLife ScienceMedical
Series UnknownAug 1, 2024
Amount Raised: $1,340,382
Draupnir Bio

Risskov, Midtjylland, Denmark

Draupnir Bio is developing a new type of cholesterol-lowering medicine which prevents blood clots in the heart.

BiotechnologyHealth CarePharmaceuticalTherapeutics
SeedJul 17, 2024
Amount Raised: $13,198,813
Outrun TX

Dundee, Dundee City, United Kingdom

Outrun TX develops a platform for the identification of therapeutics that selectively target the protein degradation pathway.

BiotechnologyHealth CareMedicalTherapeutics
SeedApr 18, 2024
Amount Raised: $10,000,000
PharmEnable

Cambridge, Cambridgeshire, United Kingdom

PharmEnable has developed a rapid and cost effective way to identify better chemical starting points to drive the discovery.

BiotechnologyLife ScienceMedicalPharmaceutical
SeedMay 22, 2023
Amount Raised: $7,460,367
QurAlis

Cambridge, Massachusetts, United States

QurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD.

BiotechnologyGeneticsHealth CarePrecision MedicineTherapeutics
Series BMar 9, 2023
Amount Raised: $88,000,000
Korro Bio

Cambridge, Massachusetts, United States

Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.

BiotechnologyHealth CarePharmaceutical
Series BJan 5, 2022
Amount Raised: $116,000,000
SOLA Biosciences

Tel Aviv, Tel Aviv, Israel

SOLA Biosciences develops a modular bioreactor called Sola that empowers people to grow cells.

Alternative MedicineBiotechnologyFood and Beverage
SeedSep 9, 2021
Libero Thera

Nihombashi-hamacho, Tokyo, Japan

Libero Thera provides drug discovery research and development services.

BiopharmaBiotechnologyLife ScienceMedical
Series UnknownMay 14, 2021
Amount Raised: $4,891,429
Outrun TX

Dundee, Dundee City, United Kingdom

Outrun TX develops a platform for the identification of therapeutics that selectively target the protein degradation pathway.

BiotechnologyHealth CareMedicalTherapeutics
SeedApr 1, 2021